−0.852NOK
−23.82 MNOK
14.15 MNOK
About GENETIC ANALYSIS AS
Sector
Industry
CEO
Ronny Hermansen
Website
Headquarters
Oslo
Founded
2008
ISIN
NO0010692130
FIGI
BBG0129CP2P9
Genetic Analysis AS develops in-vitro diagnostics tests in diseases where microbiota is involved. It is a molecular diagnostic company that provides gut microbiota analysis for testing bacterial imbalance in bowel syndrome and inflammatory bowel disease patients. The company's service products include GA-map dysbiosis test and COVID-19 fecal test and lab products include The GA-map dysbiosis test reagent kit and The COVID fecal test reagent kit. Genetic Analysis was founded in 2008 and is headquartered in Oslo, Norway.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of GEAN is 0.670 NOK — it has increased by 9.84% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NGM exchange GENETIC ANALYSIS AS stocks are traded under the ticker GEAN.
GENETIC ANALYSIS AS is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
GEAN stock is 9.84% volatile and has beta coefficient of −0.16. Check out the list of the most volatile stocks — is GENETIC ANALYSIS AS there?
GENETIC ANALYSIS AS revenue for the last quarter amounts to 3.70 M NOK despite the estimated figure of 5.50 M NOK. In the next quarter revenue is expected to reach 2.60 M NOK.
Yes, you can track GENETIC ANALYSIS AS financials in yearly and quarterly reports right on TradingView.
GEAN stock has fallen by 51.09% compared to the previous week, the month change is a 21.82% rise, over the last year GENETIC ANALYSIS AS has showed a 63.49% decrease.
GEAN net income for the last quarter is −6.67 M NOK, while the quarter before that showed −4.32 M NOK of net income which accounts for −54.29% change. Track more GENETIC ANALYSIS AS financial stats to get the full picture.
No, GEAN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, GEAN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENETIC ANALYSIS AS stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GENETIC ANALYSIS AS technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GENETIC ANALYSIS AS stock shows the sell signal. See more of GENETIC ANALYSIS AS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GENETIC ANALYSIS AS EBITDA is −27.31 M NOK, and current EBITDA margin is −217.41%. See more stats in GENETIC ANALYSIS AS financial statements.